Frank D. Sistare

Merck & Co., Inc., Rahway, NJ, USA (United States)

Biochemistry, Genetics and Molecular BiologyComputer SciencePharmacology, Toxicology and PharmaceuticsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies”.

A Collaborative Initiative to Establish Genomic Biomarkers for Assessing Tumorigenic Potential to Reduce Reliance on Conventional Rodent Carcinogenicity Studies

Toxicological Sciences(2022)10.1093/toxsci/kfac041

N/A

0DataRank · unranked

21 citations

Constance A. Mitchell, Scott S. Auerbach, Pierre R. Bushel, Heidrun Ellinger‐Ziegelbauer, Patricia A. Escobar +14 more

Applying genomics in regulatory toxicology: a report of the ECETOC workshop on omics threshold on non-adversity

Archives of Toxicology(2023)10.1007/s00204-023-03522-3

N/A

0DataRank · unranked

22 citations

Scott S. Auerbach, Martin von Bergen�, Mounir Bouhifd, Philip A. Botham, Florian Caiment +12 more

Enabling novel paradigms: a biological questions-based approach to human chemical hazard and drug safety assessment

Toxicological Sciences(2023)10.1093/toxsci/kfad124

N/A

0DataRank · unranked

6 citations

John R. Bucher, Frank D. Sistare, James L. Stevens, Grace A. Chappell, M. Clemons +4 more